
Keywords: Common variable immunodeficiency; inflammatory complications; mucosal disease; innate lymphoid cells; CVID; Common variable immunodeficiency; CVIDc; CVID with inflammatory disease; CyTOF; Mass cytometry; Id-2; Inhibitor of DNA binding 2; ILC; Innate lymph